Skip to Content
UW Health SMPH
American Family Children's Hospital
Paul M. Harari, MD close
Paul M. Harari, MD

For Patients

Need help selecting a doctor?
Call the Welcome Center at
(608) 821-4819 for personal assistance.

For Referring Physicians

How to refer a patient

Paul M. Harari, MD Print Friendly Page

Chair, Department of Human Oncology
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Harari’s medical interests include radiation oncology, head and neck oncology, and oncology training and education.


Oncology (Radiation)

UW Health Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map

Hospital Affiliation(s)

University of Wisconsin Hospital and Clinics (primary)
Veterans Hospital - Wm. S. Middleton Memorial (secondary)

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency University of Arizona Medical Center
Internship University of California-Davis Medical Center, Sacramento
Medical School University of Virginia School of Medicine, Charlottesville, VA, 1984


UW Health Patient Experience Physician Champion Award 2015

Newsweek's Top Cancer Doctors 2015

Best Doctors® in America 2014

Best Doctors® in America 2013

Madison Magazine Top Docs 2012

Best Doctors® in America 2011

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.


Our doctors provide a wide range of services. The following list represents some, but not all, of the procedures offered by this physician.

Programs & Conditions


Dr. Harari's clinical and laboratory research focuses on treatment advances for head and neck cancer patients through precision radiation techniques and the use of molecular targeted growth inhibitors combined with radiation.

PubMed Articles
Britt CJ Stein AP Patel PN Harari PM Hartig GK . Incidental Parotid Neoplasms: Pathology and Prevalence. Otolaryngol Head Neck Surg. 2015 Oct;153(4):566-8
[PubMed ID: 26019135]
Werner LR Huang S Francis DM Armstrong EA Ma F Li C Iyer G Canon J Harari PM . Small Molecule Inhibition of MDM2-p53 Interaction Augments Radiation Response in Human Tumors. Mol Cancer Ther. 2015 Sep;14(9):1994-2003
[PubMed ID: 26162687]
Li C Huang S Armstrong EA Francis DM Werner LR Sliwkowski MX van der Kogel A Harari PM . Antitumor Effects of MEHD7945A, a Dual-Specific Antibody against EGFR and HER3, in Combination with Radiation in Lung and Head and Neck Cancers. Mol Cancer Ther. 2015 Sep;14(9):2049-59
[PubMed ID: 26141946]
Morris ZS Weichert JP Saker J Armstrong EA Besemer A Bednarz B Kimple RJ Harari PM . Therapeutic combination of radiolabeled CLR1404 with external beam radiation in head and neck cancer model systems. Radiother Oncol. 2015 Jun 26;
[PubMed ID: 26123834]
Kim H Monroe JI Lo S Yao M Harari PM Machtay M Sohn JW . Quantitative evaluation of image segmentation incorporating medical consideration functions. Med Phys. 2015 Jun;42(6):3013-23
[PubMed ID: 26127054]
Magnuson WJ Urban E Bayliss RA Harari PM . Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer. Technol Cancer Res Treat. 2015 Jun;14(3):315-9
[PubMed ID: 25782188]
Stein AP Britt CJ Saha S McCulloch TM Wieland AM Harari PM Hartig GK . Patient and tumor characteristics predictive of primary parotid gland malignancy: A 20-year experience at the University of Wisconsin. Am J Otolaryngol. 2015 May-Jun;36(3):429-34
[PubMed ID: 25766621]
Kimple RJ Harari PM . The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy. Ann Transl Med. 2015 May;3(Suppl 1):S14
[PubMed ID: 26046059]
Stein AP Swick AD Smith MA Blitzer GC Yang RZ Saha S Harari PM Lambert PF Liu CZ Kimple RJ . Xenograft assessment of predictive biomarkers for standard head and neck cancer therapies. Cancer Med. 2015 May;4(5):699-712
[PubMed ID: 25619980]
Nyflot MJ Kruser TJ Traynor AM Khuntia D Yang DT Hartig GK McCulloch TM Wiederholt PA Gentry LR Hoang T Jeraj R Harari PM . Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion. Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):942-51
[PubMed ID: 25659884]
Schwartz DL Harris J Yao M Rosenthal DI Opanowski A Levering A Ang KK Trotti AM Garden AS Jones CU Harari P Foote R Holland J Zhang Q Le QT . Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522. Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):721-9
[PubMed ID: 25752384]
Chung CH Zhang Q Kong CS Harris J Fertig EJ Harari PM Wang D Redmond KP Shenouda G Trotti A Raben D Gillison ML Jordan RC Le QT . p16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinoma. J Clin Oncol. 2014 Dec 10;32(35):3930-8
[PubMed ID: 25267748]
Mohindra P Urban E Pagan JD Geye HM Patel VB Bayliss RA Bender ET Harari PM . Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance. Head Neck. 2014 Dec 1;
[PubMed ID: 25445257]
Morris ZS Harari PM . Interaction of radiation therapy with molecular targeted agents. J Clin Oncol. 2014 Sep 10;32(26):2886-93
[PubMed ID: 25113770]
Harari PM Harris J Kies MS Myers JN Jordan RC Gillison ML Foote RL Machtay M Rotman M Khuntia D Straube W Zhang Q Ang K . Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234. J Clin Oncol. 2014 Aug 10;32(23):2486-95
[PubMed ID: 25002723]
Cannon DM Geye HM Hartig GK Traynor AM Hoang T McCulloch TM Wiederholt PA Chappell RJ Harari PM . Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck. 2014 Aug;36(8):1120-5
[PubMed ID: 23804248]
Kimple RJ Harari PM . Is radiation dose reduction the right answer for HPV-positive head and neck cancer? Oral Oncol. 2014 Jun;50(6):560-4
[PubMed ID: 24134946]
Huang S Peet CR Saker J Li C Armstrong EA Kragh M Pedersen MW Harari PM . Sym004, a novel anti-EGFR antibody mixture, augments radiation response in human lung and head and neck cancers. Mol Cancer Ther. 2013 Dec;12(12):2772-81
[PubMed ID: 24130052]
Hong JC Kruser TJ Gondi V Mohindra P Cannon DM Harari PM Bentzen SM . Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):290-6
[PubMed ID: 23906930]
Kruser TJ Rice SR Cleary KP Geye HM Tome WA Harari PM Kozak KR . Acute hematologic and mucosal toxicities in head and neck cancer patients undergoing chemoradiotherapy: a comparison of 3D-CRT, IMRT, and helical tomotherapy. Technol Cancer Res Treat. 2013 Oct;12(5):383-9
[PubMed ID: 23547974]